The Dextra large-scale facility is located at the NZP New Zealand site where a range of bulk pharmaceutical intermediates and drug substances are manufactured.
Background to NZP
New Zealand Pharmaceuticals Ltd (NZP) was established in 1971 to extract and purify biochemicals from by-products of the New Zealand meat processing industry. In the 1980s the product range broadened to include a variety of other biochemicals, especially biopolymers, extracted from natural sources.
In recent years, NZP’s integrated cGMP manufacturing capability expanded into the chemical synthesis of carbohydrate and bile acid derivatives and other novel compounds with therapeutic potential.
In 2005, the private equity firm, Direct Capital www.directcapital.co.nz, purchased a 51% share of NZP. Dextra was acquired in 2009.
Owing to a strong demand for derivatives of NZP’s bile acids and a range of carbohydrates, the Company developed synthesis capability. This capability was fully realised with the opening of a dedicated synthesis facility in 2007.
NZP is situated near the city of Palmerston North in the North Island of New Zealand. The city is home to New Zealand's largest university (Massey University) and New Zealand's largest concentration of life sciences and agricultural research.
For further information on NZP, please visit www.nzp.co.nz.
Marketing and Quality
Dextra's and NZP’s success is built on excellent commercial relationships. It is highly customer focused and fosters close working collaborations in the;
· servicing of existing products
· development and manufacture of new products. 
As well as delivering products of the required quality, Dextra and NZP strive to exceed customer service requirements through a commitment to timely communication, accurate export documentation and efficient worldwide distribution.
Good Manufacturing Practices
Current Good Manufacturing Practice (GMP) is an integral part of the company's culture and ensures that all products conform to stringent customer specifications and comply with international regulatory requirements. The majority of the analytical testing is carried out in-house in a modern quality assurance laboratory.
Safety Health and Environment
Safety Health and Environmental (SH&E) issues are also fundamental to the Company's values. There is continuous investment at Dextra and NZP to further improve both safety and sustainability.
Product Development
The company has well equipped laboratories in both the United Kingdom and New Zealand, with two cGMP kilo laboratories at Reading and two pilot plants for small-scale commercial production at the Palmerston North site.